JPY 721.0
(-0.14%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 742 Million | 608 Million | 489 Million | 742 Million | 140 Million | 2.5 Billion |
Net Income | 489 Million | 1.35 Billion | 1.76 Billion | 1.74 Billion | -1.53 Billion | 1.85 Billion |
Depreciation & Amortization | 376 Million | 322 Million | 254 Million | 241 Million | 731 Million | 667 Million |
Deferred income taxes | - | -13 Million | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -486 Million | 63 Million | -288 Million | -78 Million | 21 Million | 358 Million |
Other non-cash items | -489 Million | -1.12 Billion | -1.24 Billion | -1.16 Billion | 925 Million | -379 Million |
Investing Cash Flow | -595 Million | -307 Million | 150 Million | 1.69 Billion | 1.24 Billion | -347 Million |
Investments in PPE | -222 Million | -252 Million | -204 Million | -189 Million | -317 Million | -294 Million |
Acquisitions | -306 Million | -105 Million | -233 Million | 1.21 Billion | -66 Million | -227 Million |
Investment purchases | -19 Million | -113 Million | -158 Million | -100 Million | -291 Million | -412 Million |
Sales/Maturities of investments | 136 Million | 250 Million | 927 Million | 521 Million | 1.97 Billion | 200 Million |
Other Investing Activities | -11 Million | -87 Million | -182 Million | 254 Million | -57 Million | 386 Million |
Financing Cash Flow | -863 Million | -588 Million | -653 Million | -628 Million | -2.06 Billion | -829 Million |
Debt repayment | -3 Million | -5 Million | -116 Million | -1 Billion | -6 Million | -112 Million |
Dividends payments | -860 Million | -582 Million | -532 Million | -626 Million | -797 Million | -956 Million |
Common Stock Repurchased | - | - | - | - | -1.25 Billion | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -1 Million | -5 Million | 998 Million | -1 Million | 239 Million |
Accounts receivables | -124 Million | -51 Million | -193 Million | 78 Million | 241 Million | -2 Million |
Accounts payables | 14 Million | 26 Million | 10 Million | - | -37 Million | 14 Million |
Inventory | 3 Million | -31 Million | 13 Million | 21 Million | -8 Million | -25 Million |
Other working capital | -379 Million | 119 Million | -118 Million | -99 Million | -175 Million | 371 Million |
Cash at beginning of period | 8.28 Billion | 8.56 Billion | 8.57 Billion | 6.76 Billion | 7.44 Billion | 6.11 Billion |
Cash at end of period | 7.87 Billion | 8.28 Billion | 8.56 Billion | 8.57 Billion | 6.76 Billion | 7.44 Billion |
Capital Expenditure | -222 Million | -252 Million | -204 Million | -189 Million | -317 Million | -294 Million |
Effect of forex changes on cash | - | 9 Million | - | 1 Million | - | - |
Net cash flow / Change in cash | -415 Million | -278 Million | -14 Million | 1.81 Billion | -680 Million | 1.32 Billion |
Free Cash Flow | 520 Million | 356 Million | 285 Million | 553 Million | -177 Million | 2.21 Billion |
Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 426 Million | -456 Million | 529 Million | -10 Million | 1.35 Billion | 459 Million |
Depreciation & Amortization | - | - | - | 102 Million | 322 Million | 88 Million |
Deferred income taxes | - | - | - | - | -13 Million | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | 63 Million | - |
Other non-cash items | -426 Million | 456 Million | -529 Million | 10 Million | -1.12 Billion | -459 Million |
Investing Cash Flow | - | - | - | - | -307 Million | - |
Investments in PPE | - | - | - | - | -252 Million | - |
Acquisitions | - | - | - | - | -105 Million | - |
Investment purchases | - | - | - | - | -113 Million | - |
Sales/Maturities of investments | - | - | - | - | 250 Million | - |
Other Investing Activities | - | - | - | - | -87 Million | - |
Financing Cash Flow | - | - | - | - | -588 Million | - |
Debt repayment | - | - | - | - | -5 Million | - |
Dividends payments | - | - | - | - | -582 Million | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | -1 Million | - |
Accounts receivables | - | - | - | - | -51 Million | - |
Accounts payables | - | - | - | - | 26 Million | - |
Inventory | - | - | - | - | -31 Million | - |
Other working capital | - | - | - | - | 119 Million | - |
Cash at beginning of period | - | - | - | 8.28 Billion | 8.56 Billion | 7.58 Billion |
Cash at end of period | - | - | - | 7.85 Billion | 8.28 Billion | 8.28 Billion |
Capital Expenditure | - | - | - | - | -252 Million | - |
Effect of forex changes on cash | - | - | - | - | 9 Million | - |
Net cash flow / Change in cash | - | - | - | -435 Million | -278 Million | 697 Million |
Free Cash Flow | - | - | - | 204 Million | 356 Million | 189 Million |
MJARF
0OA7
9347
4203
7116
8081